Log In
Print this Print this

apricitabine (AVX754, SPD754)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionCytidine analog nucleoside reverse transcriptase inhibitor (NRTI)
Molecular Target Not available
Mechanism of ActionNucleoside analog reverse transcriptase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection in patients who are failing therapy
Regulatory Designation
PartnerAvexa Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today